Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03598608
Title Study to Evaluate the Safety and Efficacy of a Combination of MK-4280 and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | DEU | CAN | AUS

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center ( Site 0020) RECRUITING Gilbert Arizona 85234 United States Details
City of Hope ( Site 0001) RECRUITING Duarte California 91010 United States Details
Ronald Reagan UCLA Medical Center (Radiological Sciences) ( Site 0007) RECRUITING Los Angeles California 90095 United States Details
Pacific Cancer Care ( Site 0006) ACTIVE_NOT_RECRUITING Monterey California 93940 United States Details
University of California San Francisco ( Site 0023) RECRUITING San Francisco California 94143 United States Details
Dana Farber Cancer Institute ( Site 0002) ACTIVE_NOT_RECRUITING Boston Massachusetts 02215 United States Details
Fox Chase Cancer Center ( Site 0019) COMPLETED Philadelphia Pennsylvania 19111 United States Details
Texas Oncology-Austin Midtown ( Site 8002) COMPLETED Austin Texas 78705 United States Details
Concord Repatriation & General Hospital ( Site 0203) RECRUITING Concord New South Wales 2139 Australia Details
Princess Alexandra Hospital ( Site 0204) RECRUITING Woollongabba Queensland 4102 Australia Details
Monash Health ( Site 0201) RECRUITING Clayton Victoria 3168 Australia Details
St Vincent s Hospital (Melbourne) Limited ( Site 0202) RECRUITING Fitzroy Victoria 3065 Australia Details
BC Cancer ( Site 0107) RECRUITING Vancouver British Columbia V5Z 1L3 Canada Details
CancerCare Manitoba ( Site 0101) RECRUITING Winnipeg Manitoba R3E 0V9 Canada Details
Princess Margaret Cancer Centre ( Site 0100) RECRUITING Toronto Ontario M5G 2M9 Canada Details
Jewish General Hospital ( Site 0105) RECRUITING Montreal Quebec H3T 1E2 Canada Details
U. klinikum Koeln AOER ( Site 0326) ACTIVE_NOT_RECRUITING Koeln Nordrhein-Westfalen 50937 Germany Details
Universitaetsklinikum Leipzig AOeR ( Site 0327) RECRUITING Leipzig Sachsen 4103 Germany Details
Rambam Medical Center ( Site 0382) RECRUITING Haifa 3109601 Israel Details
Hadassah Ein Karem Jerusalem ( Site 0383) RECRUITING Jerusalem 9112001 Israel Details
Chaim Sheba Medical Center. ( Site 0380) RECRUITING Ramat Gan 5262001 Israel Details
Sourasky Medical Center ( Site 0381) RECRUITING Tel Aviv 6423906 Israel Details
A.O. Universitaria Policlinico S. Orsola-Malpighi ( Site 0351) RECRUITING Bologna Emilia-Romagna 40138 Italy Details
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori ( Site 0354) RECRUITING Meldola Forli-Cesena 47014 Italy Details
Humanitas-U.O di Oncologia medica ed Ematologia ( Site 0352) RECRUITING Rozzano Milano 20089 Italy Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field